OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
214,467,875
Total 13F shares
41,528,139
Share change
-3,146,389
Total reported value
$289,118,916
Put/Call ratio
101%
Price per share
$6.97
Number of holders
137
Value change
-$36,286,646
Number of buys
74
Number of sells
66

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2021

As of 31 Dec 2021, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,528,139 shares. The largest 10 holders included Opaleye Management Inc., SUMMER ROAD LLC, BlackRock Inc., VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, STATE STREET CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, EMERALD ADVISERS, LLC, and EMERALD MUTUAL FUND ADVISERS TRUST. This page lists 137 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.